Reprogramming differentiated cells toward stem cells may have long-term applications in stem-cell research and regenerative medicine.
Here we report on the dedifferentiation of human epidermal keratinocytes into their precursor cells in vitro with basic fibroblast growth factor (bFGF) but not external gene intervention. After incubation of human terminally differentiating keratinocytes, some of the surviving keratinocytes reverted from a differentiated to a dedifferentiated state, as evidenced by re-expression of biological markers of native keratinocyte stem cells (nKSCs), including b b 1 -integrin, CK19 and CK14. Moreover, these dedifferentiation-derived KSCs (dKSCs) showed an ability for high colony formation correlated with cell cycle analysis showing a marked accumulation in S phases, acquired a similar regional distribution of both a a 6 -integrin and CD71 expression at the ultrastructural level, and had a increased proliferative capacity by releasing telomerase from nucleolar sites to nucleoplasmic distribution. However, on comparing dKSCs with nKSCs, 2 points seem noteworthy: (1) the proportion of transit amplifying cells in dKSCs treated with bFGF is much higher than that in nKSCs and (2) regional differences exist in the subcellular localization of telomerase in nKSCs and dKSCs. Most nKSCs showed a prominent nucleolar concentration of human telomerase reverse transcriptase expression, whereas most dKSCs showed a more diffuse intranuclear distribution of telomerase or even signal depletion at nucleoli relative to the general nucleoplasm. These results indicate that bFGF could induce the terminally differentiating epidermal keratinocytes to convert into their precursor cells, which offers a new approach for generating residual healthy stem cells for wound repair and regeneration.
Colony-Forming Efficiency Cells were harvested and seeded at 5ϫ10 3 per well to a 6-well plate and cultured for another 7 d in Epilife medium that was changed 4 d after plating. Colonies consisting of 5-10 cells and Ͼ10 cells were counted separately under a microscope. This assay was performed 5 times.
MTT Cell Proliferation Assay Briefly, cells were plated in 96-well plates (Costar) with addition of 100 ng/ml bFGF for different periods of time (6, 12, 24, 36, 48, 72 h) at 37°C in 5% CO 2 humidified atmosphere. Subsequently, 20 ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) were added to 30 ml of medium per well and incubated for 4 h until purple precipitate was visible. Discarded the media and dried the wells, then added dimethyl sulfoxide (DMSO) 50 ml and shook for 5 min until the crystals were dissolved. Finally, the absorbance was read at 490 nm. The number of surviving cells was directly proportional to the level of the formazan product created. The last column of each 96-well plate did not contain cells and was used as a blank and cells without bFGF treatment were used as negative controls.
Immunochemistry and Confocal Microscopy Analysis Cells were fixed for 30 min at room temperature with PBS (phosphate buffered saline) containing 4% paraformaldehyde. For immunohistochemical analysis, cells were incubated in 0.3% H 2 O 2 to block endogenous peroxidase activity, then were exposed to the primary antibodies mouse monoclonal anti-human CK10 (1 : 100), CK14 (1 : 100), CK19 (1 : 100) and b 1 -integrin (1 : 50) (all Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) overnight at 4°C. Subsequent immunostaining involved use of the ChemMate TM EnVi-sion™ detection kit (DAKO Inc., Carpinteria, CA, U.S.A.). Color development was detected by using DAB staining method and lightly counterstained with Mayer hematoxylin.
For indirect immunofluorescence, cells grown on coverslips were fixed with 4% paraformaldehyde in PBS for 2 h. They were then permeabilized in 1% Triton X-100 in PBS for 10 min at 4°C, incubated with a primary antibody (for 16 h at 4°C), mouse anti-human telomerase reverse transcriptase (hTERT; 1 : 50), then probed with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulin G (1 : 50) (all Santa Cruz) for 2 h at 25°C. Additionally, cells were incubated for 16 h with a 6 -integrin-FITC (1 : 50) and CD71-PE (1 : 100, both Santa Cruz) at 4°C for double-labeling observation. After a thorough washing in PBS, cells were mounted in Gelvatol (Monsanto Chemicals) and examined under a Leica DMRXA microscope equipped with an air-cooled camera controlled by QFISH software (Leica imaging systems Ltd., Cambridge, U.K.). For controls, the primary antibody was omitted. Nuclei were stained blue with Hoechst33342 (Sigma-Aldrich).
Flow Cytometry For cell cycle analysis, cells were synchronized as above, exposed to bFGF for 36 to 48 h, then collected, washed with PBS, fixed and permeabilized in 70% ethanol (Ϫ20°C) at 4°C for 24 h. After washing with PBS, the cells were treated with RNase A (40 mg/ml) at 37°C for 20 min. Cells were then incubated in 3 mg/ml propidium iodide (Sigma-Aldrich, St. Louis, MO, U.S.A.) for 5 min at room temperature and analyzed by flow cytometry.
To compare protein levels in different keratinocyte samples, cells were cultured to 80% confluence, harvested and processed for CK19 (1 : 100), CK14 (1 : 100), CK10 (1 : 100), and b 1 -integrin (1 : 50) labeling. The primary antibodies were detected with FITC-conjugated goat anti-mouse IgG (1 : 100, Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). A blank control was prepared by replacing the primary antibodies with 100 ml PBS. The percentage CK10 ϩ , CK19 ϩ , CK14 ϩ and b 1 -integrin ϩ cells was detected on flow cytometry (FACS scan; Beckton Dickinson, San Jose, CA, U.S.A.).
In Vitro Cell Transfection The gene constructs containing the human bFGF cDNA and enhanced green fluorescent protein (EGFP) coding region (a gift from Dr. Shi M., Department of Molecular Immunology, Institute of Basic Medical Sciences) were transfected into differentiated HEK cells in 6-well culture dishes of 80-90% confluency with Lipofectamine TM 2000 reagent (Invitrogen, Carlsbad, CA, U.S.A.), according to the manufacturer's instructions. Briefly, Lipofectamine TM 2000 (30 ml) diluted in 1470 ml EpiLife medium was mixed with 30 mg purified pEGFP-C 1 -FGF2 plasmid DNA diluted in 1500 ml EpiLife medium. The DNA-Lipofectamine TM mixtures were incubated for 20 min at room temperature and then added to each well at a final volume of 2 ml. Twelve hours later, infected cells were continuously cultured in EpiLife Medium supplemented with 1% human keratinocyte growth supplement after removal of the transfection medium. After 48 h, transfection results were observed and photographed under a fluorescence microscope. Cells transfected with pEGFP-C 1 vector were used as negative controls.
Analysis of pEGFP Imaging Immunofluorescence Staining After DNA transfection, the cells grown on coverslips were immunofluorescence stained using the following primary antibodies (for 16 h at 4°C): mouse monoclonal anti-human CK10 (1 : 100), CK14 (1 : 100), CK19 (1 : 100) and b 1 -integrin (1 : 50) (all Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) overnight at 4°C, and then incubated with secondary antibody Goat Anti-Mouse IgG PE (Santa Cruz Biotechnology, dilution 1 : 100) for 2 h at 25°C. Immunofluorescent images were obtained using a confocal microscope.
Real-Time PCR RNA was isolated by the RNAgents total RNA isolation system (Promega Corp., Madison, WI, U.S.A.) with DNase I (Invitrogen) treatment. Total RNAs were reverse transcribed using oligo(dT) primer according to the manufacturer's instructions (Promega). cDNA were adjusted to equal levels by PCR amplification with primers to b-actin. Primers were designed to ensure the uniqueness for each gene. For a list of primers used see Table 1 .
Statistics All experiments were repeated at least 3 times, unless otherwise indicated. Data are presented as meanϮS.D. 
Statistical analysis involved use of one-way analysis of variance (ANOVA) followed by a Tukey multiple comparison test. A pϽ0.05 was considered statistically significant.
RESULTS

Cultivation of the Human Basal Keratinocyte Stem Cells
In the process of cultivation, we observed that human basal keratinocytes were adherent epidermal cells with cobble stone-like morphology which changes with increasing passages. At early passages (from P1 to P3), the isolated basal keratinocytes showed no obvious difference in the cell morphology and colony-forming potential. Particularly, the basal keratinocytes within 3 passages showed not only clonogenicity but also the ability to reconstitute an epidermal equivalent-like structure with regular stratification (see Fig.  1 ). However, with the increasing number of cell passages (from P4 to P6), the morphological alterations in basal keratinocytes such as enlargement and flattening of the cells, as well as a decrease in nuclear-cytoplasmic ratio, could be observed which accompanied by the decrease of cell cloneforming activity and longer average doubling time. In passage 7 and 8, cells were found completely flattening and entered a crisis phase which subsequently underwent apoptosis. Immunohistochemical staining of basal keratinocytes in different passages proved that the first-passage basal keratinocytes were positive for b 1 -integrin, CK19 and 14, yet negative for CK10 expression. Although we found no significant difference in the expression levels of above proteins in the basal keratinocytes between first and third passage, however, the expression of b 1 -integrin, CK19 and 14 reduced gradually, and CK10 content increased relatively with the increase of cell passages (pϾ3). Table 2 summarises the number of basal keratinocytes which were positive for established markers of KSCs. These results provided that the isolated basal keratinocytes within 3 passages had some properties of keratinocyte stem cells such as the tight, cobblestone-like morphology with large nuclear-cytoplasmic ratio, the ability of cloning formation and to reconstitute a stratified epidermal equivalent-like structure, and high levels of b 1 -integrin expression. Thus, we used the isolated basal keratinocytes at passage 3 (low passages) to define the undifferentiated keratinocyte stem cells in epidermis.
Establishment and Initial Characterization of Human Terminally Differentiating Keratinocytes In order to test the "stem" of HEK cells, we performed immunocytochemistry on HEK cells in parallel with the isolated basal keratinocytes upon serial passages, and the results revealed that there is no significant difference in the cell morphology and multiplication potential between HEK cells and basal keratinocytes during the process of differentiation. The culture of HEK cells could be passaged at least 2 times within 1 week (from P1 to P3) and maintained a high level of b 1 -integrin expression for about 3 to 4 d after initial plating of the cells. After approximately 5 passages, some large, differentiating cells were readily observed interspersed among the cobble-stone HEK cells. When propagated beyond 7 passages, HEK cells consisted almost exclusively of large flattening differentiating cells, and the expression of putative keratinocyte stem cell markers, including b 1 -integrin, CK19, CK14, decreased dramatically, whereas the expression of CK10 increased. Thus, we used the HEK cells that propagated up to 7 passages (high passage) to define the terminally differentiating keratinocytes in epidermis (Fig. 1C) . The criteria of terminally differentiating keratinocytes employed by us were: (1) morphological alteration from cobble stone-like shape to flattened shape, and (2) loss of the expression of some putative epidermal stem cell markers assessed by immunostaining of b 1 -integrin, CK19, and CK14, as well as the up-regulated expression of CK10. bFGF Increases Proliferative Capacity of Human Terminally Differentiating Keratinocytes After cell culture for 7 passages, HEK cells were flattened and formed cell-tocell contacts, which resembled terminally differentiating epidermal keratinocytes in vivo. To elucidate whether these HEK cells could regain the ability of clonogenicity after growth factor treatment, the number of colonies with 5-10 cells and those with Ͼ10 cells were counted blindly. We found that clusters of round-shaped cells with large nuclearcytoplasmic ratio became detectable around differentiating HEK cells, after 36 to 48 h in the presence of bFGF, and expanded progressively thereafter (see Fig. 1D ). The number of colonies with 5-10 cells and Ͼ10 cells in the bFGF treatment group were increased 15.3-and 11-fold, respectively, as compared with control (terminally differentiating keratinocytes), with no significant difference between treated HEK cells and nKSCs (pϾ0.05). Figure 2 showed a highly significant capacity of terminally differentiating epidermal keratinocytes to give rise to colonies after bFGF treatment. Interestingly, these dedifferentiation-derived cells showed clonogenicity as well as the ability to reconstitute a stratified epidermal equivalent-like structure. Two other members of the growth factor, EGF and fetus extracts, did not increase colony number, and bFGF promoted cell proliferation efficiency of HEK cells in a time-dependent manner, with a peak at 36 to 48 h. (Fig. 2E) .
We also studied the changes in the HEK cell cycle in the presence or absence of bFGF ( Fig. 3) : The results suggest that bFGF could activate the cell cycle progression of terminally differentiating epidermal keratinocytes and induce them to re-enter the cell cycle and cleave to form smaller or mononucleated cells, with a large ratio of nucleus to cytoplasm.
bFGF Induces the Re-expression of Putative Markers of KSCs in Human Terminally Differentiating Keratinocytes. Phenotypic and Morphological Changes To further characterize the morphological alteration of human keratinocytes, we examined the expression of b 1 -integrin and some putative biological markers in HEK cells after bFGF treatment. Immunohistochemical staining revealed the expression of b 1 -integrin, CK19 and CK14 upregulated, and the expression of CK10 significantly downregulated in HEK cells after incubation with bFGF, with no significant difference from the expression in nKSCs (see Fig. 4 ). In agreement with our findings, flow cytometry analysis of the phenotypic changes in HEK cells after bFGF treatment revealed that essentially all cells showed strong CK14 staining (from 67.26 to 99.82%) as compared with the control. The proportion of b 1 -integrin ϩ and CK19 ϩ populations was increased, from 3.06 to 20.64% and 15.74 to 42.66%, respectively, and the CK10 ϩ population was decreased from 98.56 to 26.76%. The percentages of b 1 -integrin ϩ , CK19 ϩ , CK14 ϩ and CK10 ϩ cells in nKSCs were 56.53%, 73.47%, 89.56% and 5.89% respectively (see Fig. 5 ). Meanwhile, to rule out the possibility that bFGF act to increase the survival of a subpopulation of already present stem cells rather than induce the actual reprogramming of the terminally differentiating keratinocytes, the plasmid pEGFP-C 1 -FGF2 was transfected into HEK cells and the results directly proved that terminally differentiating keratinocytes were induced to reverse their differentiated process and reproduce immature, keratinocyte stem-like cells-dedifferentiation-derived KSCs (dKSCs)-by induction with bFGF in vitro (Fig. 6) .
Furthermore, the mRNA expression of the above superficial proteins was analysed by RT-PCR. Similar to the immunohistochemical results, the relative mRNA expression of b 1 -integrin, CK19 and CK14 increased 1.5-, 2.6-and 1.6fold, respectively, in the bFGF-treated cells, whereas CK10 mRNA level was downregulated, by approximately 2.7-fold, as compared to the control (pϽ0.01) (see Fig. 7 ). The expression of b 1 -integrin, CK19 and CK10 did not differ from that in the native keratinocyte stem cells (pϾ0.05). However, the expression of CK14 in bFGF-treated cells was increased 1.4fold as compared with nKSCs (pϽ0.01), which suggests that the population of transit amplifying (TA) cells in dKSCs is larger than that in nKSCs.
CD71 and a a 6 -Integrin Expression Integrins are ex-pressed at high levels on the surface of multipotent epithelial stem cells within the bulge area, which may contribute to their intercellular adhesion and explain their restricted mobility. 11) Tani and colleagues reported on a successful separation of KSCs from their subpopulations by using the cell-surface markers a 6 -integrin and CD71. 12) Our previous study showed that a 6 -integrin and CD71 were co-expressed in KSCs, with regional differences in the distribution of a 6 -integrin and CD71 in KSCs and TA cells (Figs. 8A-C). Especially, CD71, transferring receptor, which was present primarily in the nuclei of immature TA cells and tended to spread from the nuclei to plasma membrane during the differentiating stages of TA cells, may play a key role in the regulation of development, homeostasis and differentiation of skin stem cell. To address this, we detected the co-expression of a 6 -integrin and CD71 in the dKSCs in this study by using doublelabeling immunofluorescence: the expression of a 6 -integrin predominantly localized on the membrane or in cytoplasm of dKSCs (Fig. 8D) , whereas CD71 was present in the nuclei and cytoplasm of dKSCs, which corresponded to the a 6 -integrin-CD71 co-localization in nKSCs (Fig. 8E) .
bFGF Induces the Subcellular Localization of hTERT in Human Terminally Differentiating Keratinocytes Previous studies showed catalytically active human telomerase with a regulated intranuclear localization. The release of telomerase to the nucleoplasm from sequestration at nucleolar sites was enhanced at the time of telomere replication in normal somatic cells, whereas tumour and transformed cells showed an almost complete dissociation of telomerase from nucleoli at all stages of the cell cycle. 13) To investigate the subcellular localization of telomerase in human epidermal keratinocytes after bFGF treatment, the native KSCs and dKSCs were fixed for immunofluorescent staining to examine the cellular distribution of the telomerase RNA. The majority of nKSCs showed prominent nucleolar fluorescence, which indicates a subnuclear concentration of hTERT expression (Figs. 9A-C). However, most dKSCs showed a more diffuse intranuclear telomerase distribution or even signal depletion at nucleoli relative to the general nucleoplasm, as compared with that in nKSCs (Figs. 9D-F). On breakdown of the nuclear envelope in mitosis, the hTERT expression became diffuse throughout the whole cell in dKSCs (data not shown). Meanwhile, hTERT expression was downregulated in terminally differentiating epidermal keratinocytes ( Figs. 9G-I) .
DISCUSSION
In the present study, we demonstrated that bFGF have an important role on the induction of the dedifferentiated process in human somatic epidermal keratinocytes in vitro. After incubation with bFGF, terminally differentiating epi- dermal keratinocytes showed changes at 4 major levels: (1) they exhibited an increase in cell proliferative capacity as evidenced by the high colony-forming efficiency and marked cell-cycle progression; (2) they acquired the morphological features of nKSCs; with re-expression of some biological markers of KSCs, including b 1 -integrin, CK19 and CK14;
(3) importantly, these dedifferentiation-derived stem-celllike cells had not only phenotypic and morphological characteristics similar to those of nKSCs but also similar regional distribution of a 6 -integrin and CD71 at the ultrastructural level; and (4) they had a higher proliferative capacity by their releasing more telomerase from nucleolar sites to the nucleoplasm, which increases the opportunity for access to chromatin substrates. Thus, terminally differentiating epidermal keratinocytes are not as irreversibly committed to a pathway as was originally believed. On the contrary, they can acquire some stem cell characteristics by the modulation with bFGF treatment.
Dedifferentiation is the progression of cells from a moredifferentiated to a less-differentiated state and may occur during development, repair and regeneration of tissue in plants, vertebrates and even mammals. 14, 15) Adult KSCs have long been considered cutaneous lineage-committed cells with self-renewing or differentiating abilities to maintain homeostasis in epidermis. However, recent studies have shown that extensive tissue-regenerative ability depends on nKSCs, as expected, as well as the immediate progeny of these stem cells, even early differentiating cells. 16) One paradigm is the regeneration of multilineage skin epithelia by post-mitotic differentiated keratinocytes when placed in a suitable tissue microenvironment. 17) Another example of reprogramming events is the derivation of pluripotent embryonic stem cells and the birth of cloned offspring from differentiated somatic cell nuclei transplanted into an unfertilized oocyte. 18) We previously found that the recombinant human epidermal growth factor could induce the reversion of differentiated epidermal cells into stem cells or stem cell-like cells in vivo. 19, 20) Therefore, extrinsic factors in the cellular environment can influence the developmental fate of somatic epidermal keratinocytes, and we can achieve dedifferentiaton by remodeling a microenvirnoment composed of intrinsic and extrinsic cellular molecules.
FGF signalling in specification of embryonic skin is coordinated with Wnt and bone morphogenic protein (BMP) signaling. 21) Pioneering studies on chicks and mice revealed that FGFs and their receptors are thought to be key paramount for the signaling that leads to mesenchymal-bud-promoting regeneration. 22, 23) For example, FGFR-1 and FGFR-2 (bFGF) are expressed in the wound epithelium of limbs at stages that permit regeneration, but they are absent from the wound epithelium of limbs that are unable to regenerate. 24) Importantly, when FGF high-expressing amputated limbs were treated with FGFR inhibitors, regeneration was impaired.
Meanwhile, a study of Grinspan and co-workers revealed an unexpected complexity in the response of oligodendrocytes to FGF signaling that bFGF induced oligodendroglial dedifferentiation if oligodendroglial DNA synthesis could occur but caused oligodendroglial apoptosis when oligodendroglial DNA synthesis was prevented. 25) Furthermore, bFGF can also induce the telomerase expression in both rat lung fibroblasts 26) and human endothelial cells, 27) and play a functional role in preventing the early onset of senescence in human umbilical vein endothelial cells. 28) In this study, we investigated the effect of bFGF on cellfate determination of human terminally differentiating keratinocytes and found that it could induce these cells to revert from a differentiated to a dedifferentiated state. These dedifferentiation-derived cells exhibited an increase in cell proliferative capacity and re-expressed b 1 -integrin, CK19 and CK14, which are thought to be molecular markers of KSCs. 29) Moreover, although the dKSCs have some similarities with nKSCs, whether the reported dKSCs are functionally relevant and whether they could be a source of transplantable, therapeutically effective epidermal cell precursors is unknown because of the following reasons. First, although in both cases the cells remain multipotent and express markers of KSCs, flow cytometry revealed the proportion of TA cells in dKSCs was much higher than that in nKSCs. Especially, mRNA expression results were consistent with fluorescence labeling results, showing a higher level of b 1 -integrin, CK19 and CK10 expression in nKSCs, as well as downregulated expression of CK14, than in dKSCs. Second, regional differences existed in the subcellular localization of telomerase in nKSCs and dKSCs: most of the nKSCs showed a Representative photographs of a 6 -integrin (light grey) expression in nKSCs (A), dKSCs (D), and control cells (G). Representative photographs of CD71 (grey) expression in nKSCs (B), dKSCs (E), and control cells (H). The expression of a 6 -integrin mainly localized in the cytoplasm of nKSCs and the nuclei and cytoplasm of transit activating (TA) cells. CD71 was present primarily in the nuclei of immature TA cells and tended to spread from the nuclei to plasma membrane during the differentiation stages of TA cells. Scale barϭ100 mm. Fig. 9 . Immunofluorescent Analysis of Human Telomerase Reverse Transcriptase (hTERT) Expression in Dedifferentiated KSCs prominent nucleolar concentration of hTERT expression, whereas most of the dKSCs showed a more diffuse intranuclear telomerase distribution or even signal depletion at nucleoli relative to the general nucleoplasm. Telomerase remains catalytically active throughout the cell cycle but is regulated in its access to chromatin substrates by a cell-cycledependent release from its tethering at nucleolar sites. 13) The fluorescent staining of telomerase in KSCs co-localizing with nucleoli is consistent with the nucleolar stage in telomerase biogenesis such as RNA maturation and/or ribonucleoprotein assembly. 30) When bFGF induced the terminally differentiating epidermal keratinocytes to convert into their precursor cells or stem cells, the cells regained strong proliferation capacity and re-entered the cell cycle with the release of more telomerase from the nucleolus to nucleoplasm, which ultimately increased the opportunity for telomerase access to chromatin.
Combined with our findings above, terminally differentiating keratinocytes could undergo a reverse process to become epidermal precursor cells, as evidenced by cellular changes at 3 levels: protein expression (re-expression of stem-cell markers), morphology (small cell size, ultrastructural distribution of CD71 and a 6 -integrin and high ratio of nucleus to cytoplasm) and function (regaining the powerful proliferation activity). However, the dKSCs reported here were more likely TA cells, a subpopulation of basal KSCs, which therefore supports the high colony-forming efficiency, long-term proliferative potential, high levels of CK14 expression and enhanced telomerase activity. The application of endogenous regeneration in regenerative medicine is based on inducing the regeneration of damaged or lost tissues from residual tissues in situ. Here, we introduce a novel method to reprogram somatic epidermal keratinocytes into their precursor cells by induction with bFGF rather than genes, which provides an attractive way to generate residual healthy stem cells for the repair and regeneration of skin tissues.
